Publicação: Preliminary safety analysis of an expanded access program for decitabine in subjects with myelodysplastic syndrome (MDS)
dc.contributor.author | Pereira, J. | |
dc.contributor.author | Vaz, J. | |
dc.contributor.author | Apa, A. | |
dc.contributor.author | Lorand-Metze, I. | |
dc.contributor.author | Melo, L. Niero [UNESP] | |
dc.contributor.author | Zanichelli, M. A. | |
dc.contributor.author | Magalhaes, S. | |
dc.contributor.author | Chauffaille, M. L. | |
dc.contributor.author | Bortolheiro, T. C. | |
dc.contributor.author | Uehara, R. | |
dc.contributor.author | Novita, P. | |
dc.contributor.author | Lotito, A. P. Navarrette | |
dc.contributor.institution | Universidade de São Paulo (USP) | |
dc.contributor.institution | Ctr Tratamento Oncol | |
dc.contributor.institution | INCA | |
dc.contributor.institution | Universidade Estadual de Campinas (UNICAMP) | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | Hosp Brigadeiro | |
dc.contributor.institution | HEMOCE | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Santa Casa Misericordia São Paulo | |
dc.contributor.institution | Janssen Cilag Brazil | |
dc.date.accessioned | 2014-05-20T15:33:14Z | |
dc.date.available | 2014-05-20T15:33:14Z | |
dc.date.issued | 2010-06-01 | |
dc.description.affiliation | Univ São Paulo, Hosp Clin, Fac Med, São Paulo, Brazil | |
dc.description.affiliation | Ctr Tratamento Oncol, Brasilia, DF, Brazil | |
dc.description.affiliation | INCA, Rio de Janeiro, Brazil | |
dc.description.affiliation | Univ Estadual Campinas, Campinas, Brazil | |
dc.description.affiliation | UNESP, Botucan, Brazil | |
dc.description.affiliation | Hosp Brigadeiro, São Paulo, Brazil | |
dc.description.affiliation | HEMOCE, Fortaleza, Ceara, Brazil | |
dc.description.affiliation | Univ Fed São Paulo, São Paulo, Brazil | |
dc.description.affiliation | Santa Casa Misericordia São Paulo, São Paulo, Brazil | |
dc.description.affiliation | Janssen Cilag Brazil, São Paulo, Brazil | |
dc.description.affiliationUnesp | UNESP, Botucan, Brazil | |
dc.format.extent | 560-561 | |
dc.identifier | http://online.haematologica.org/eha15/browserecord.php?-action=browse&-recid=7466 | |
dc.identifier.citation | Haematologica-the Hematology Journal. Pavia: Ferrata Storti Foundation, v. 95, p. 560-561, 2010. | |
dc.identifier.issn | 0390-6078 | |
dc.identifier.uri | http://hdl.handle.net/11449/41926 | |
dc.identifier.wos | WOS:000279051302028 | |
dc.language.iso | eng | |
dc.publisher | Ferrata Storti Foundation | |
dc.relation.ispartof | Haematologica-the Hematology Journal | |
dc.relation.ispartofjcr | 9.090 | |
dc.relation.ispartofsjr | 3,063 | |
dc.rights.accessRights | Acesso aberto | |
dc.source | Web of Science | |
dc.title | Preliminary safety analysis of an expanded access program for decitabine in subjects with myelodysplastic syndrome (MDS) | en |
dc.type | Resumo | |
dcterms.license | http://www.haematologica.org/site/misc/authors.xhtml | |
dcterms.rightsHolder | Ferrata Storti Foundation | |
dspace.entity.type | Publication |
Arquivos
Licença do Pacote
1 - 2 de 2
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: